Immunotherapy with autologous tumor cells engineered to secrete Tag7/PGRP, an innate immunity recognition molecule

Journal of Gene Medicine

Volumn 6, Issue 7, 2004, Pages 798-808

  Larin, Sergey S ^a   Korobko, Elena V ^a,c,d   Kustikova, Olga S ^a,e   Borodulina, Olga R ^a   Raikhlin, Natan T ^b   Brisgalov, Igor P ^b   Georgiev, Georgii P ^a   Kiselev, Sergei L ^a  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c UNIVERSITY OF OSLO   (Norway)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Adenocarcinoma; Gene therapy; Melanoma; PGRP; Plasmacytoid dendritic cells; Tag7

Indexed keywords

PEPTIDOGLYCAN; PROTEIN TAG7; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL BASED GENE THERAPY; CONTROLLED STUDY; DNA MODIFICATION; GENE DELIVERY SYSTEM; GENETIC ENGINEERING; GENETIC TRANSFECTION; GROWTH RATE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA HYBRIDIZATION; TUMOR CELL; TUMOR GROWTH;

ANIMALIA; INSECTA; MUS MUSCULUS;

EID: 5444275249     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.560     Document Type: Article

References (41)

1. Kiselev SL, Kustikova OS, Korobko EV, et al. Molecular cloning and characterization of the mouse tag7 gene encoding a novel cytokine. J Biol Chem 1998; 273: 18 633-18 639.
2. Kang D, Liu G, Lundstrom A, et al. A peptidoglycan recognition protein in innate immunity conserved from insects to humans. Proc Natl Acad Sci U S A 1998; 95: 10 078-10 082.
3. Tydell CC, Yount N, Tran D, et al. Isolation, characterization, and antimicrobial properties of bovine oligosaccharide-binding protein. A microbicidal granule protein of eosinophils and neutrophils. J Biol Chem 2002; 277: 19 658-19 664.
4. Liu C, Xu Z, Gupta D, Dziarski R. Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J Biol Chem. 2001; 276: 34 686-34 694.
5. Werner T, Liu G, Kang D, et al. A family of peptidoglycan recognition proteins in the fruit fly Drosophila melanogaster. Proc Natl Acad Sci U S A 2000; 97: 13 772-13 777.
6. Mirkina H, Kibardin AV, Korneeva EA, et al. Cloning and study of novel mammalian genes with structural homology with phage lysozyme. Genetika 2000; 36: 1492-1500.
7. Rehman A, Taishi P, Fang J, et al. The cloning of a rat peptidoglycan recognition protein (PGRP) and its induction in brain by sleep deprivation. Cytokine 2001; 13: 8-17.
8. Yoshida H, Kinoshita K, Ashida M. Purification of a peptidoglycan recognition protein from hemolymph of the silkworm, Bombyx mori. J Biol Chem 1996; 271: 13 854-13 860.
9. Lo D, Tynan W, Dickerson J, et al. Peptidoglycan recognition protein expression in mouse Peyer's Patch follicle associated epithelium suggests functional specialization. Cell Immunol 2003; 224: 8-16.
10. Liu C, Gelius E, Liu G, et al. Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J Biol Chem 2000; 275: 24 490-24 499.
11. Michel T, Reichhart JM, Hoffmann JA, et al. Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein. Nature 2001; 414: 756-759.
12. Gottar M, Gobert V, Michel T, et al. The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein. Nature 2002; 416: 640-644.
13. Kelly JM, Darcy PK, Markby JL, et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 2002; 3: 83-90.
14. Soloski MJ. Recognition of tumor cells by the innate immune system. Curr Opin Immunol 2001; 13: 154-162.
15. Ma Y, Uemura K, Oka S, et al. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding protein-dependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 1999; 96: 371-375.
16. Hasegawa T, Matsuguchi T, Noda K, et al. Toll-like receptor 2 is at least partly involved in the antitumor activity of glycoprotein from Chlorella vulgaris. Int Immunopharmacol 2002; 2: 579-589.
17. Hock H, Dorsch M, Kunzendorf U, et al. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci U S A 1993; 90: 2774-2778.
18. Tepper RI, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989; 57: 503-512.
19. Watanabe Y, Kuribayashi K, Miyatake S, et al. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA 1989; 86: 9456-9460.
20. Blankenstein T, Qin ZH, Uberla K, et al. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med 1991; 173: 1047-1052.
21. Seino K, Kayagaki N, Okumura K, et al. Antitumor effect of locally produced CD95 ligand. Nat Med 1997; 3: 165-170.
22. Colombo MP, Forni G. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 1994; 15: 48-51.
23. Stoppacciaro A, Paglia P, Lombardi L, et al. Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines. Eur J Immunol 1997; 27: 2375-2382.
24. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual (2nd edn). Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989; 1847-1875.
25. Mayer RJ, Walker JH. Immunochemical procedures. In Immunochemical Methods in Cell and Molecular Biology, Academic Press: San Diego, 1987; 259-281.
26. Nikolic T, Dingjan GM, Leenen PJ, et al. A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics. Eur J Immunol 2002; 32: 686-692.
27. Lian ZX, Okada T, He XS, et al. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol 2003; 170: 2323-2330.
28. Lu L, Bonham CA, Liang X, et al. Liver-derived DEC205 + B220 + CD19-dendritic cells regulate T cell responses. J Immunol 2001; 166: 7042-7052.
29. Vieweg J, Gilboa E. Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment. Cancer Invest 1995; 13: 193-201.
30. Stingl G, Brocker EB, Mertelsmann R, et al. Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Hum Gene Ther 1996; 7: 551-563.
31. Sun Y, Jurgovsky K, Moller P, et al. Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study. Gene Ther 1998; 5: 481-490.
32. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-305.
33. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296: 298-300.
34. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
35. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443-451.
36. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099-1103.
37. Schnare M, Barton GM, Holt AC, et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947-950.
38. Hanna N. Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev 1982; 1: 45-64.
39. Budzynski W, Radzikowski C. Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol 1994; 16: 319-346.
40. Coffman RL, Weissman IL. B220: a B cell-specific member of the T200 glycoprotein family. Nature 1981; 289: 681-683.
41. Ballas ZK, Rasmussen W. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1 + CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset. J Immunol 1993; 150: 17-30.